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ABSTRACT
Although the basic components and mechanisms of
mitochondrial transcription in mammals have been
described, the components involved in mRNA
processing, translation and stability remain largely
unknown. In plants, pentatricopeptide domain RNA-
binding proteins regulate the stability, expression
and translation of mitochondrial transcripts; there-
fore, we investigated the role of an uncharacterized
mammalian pentatricopeptide domain protein,
(PTCD1), in mitochondrial RNA metabolism. We
show that PTCD1 is a mitochondrial matrix protein
which associates with leucine tRNAs and precursor
RNAs that contain leucine tRNAs. Knockdown of
PTCD1 in 143B osteosarcoma cells did not change
mitochondrial mRNA levels; however, it increased
the abundance precursor RNAs and of leucine
tRNAs and PTCD1 overexpression led to a reduction
of these RNAs. Lowering PTCD1 in cells increased
levels of several mitochondria-encoded proteins
and Complex IV activity, suggesting that PTCD1
acts as a negative regulator of leucine tRNA levels
and hence mitochondrial translation.
INTRODUCTION
Human mitochondrial DNA (mtDNA) is a circular
double-stranded genome that encodes 22 tRNAs,
2 rRNAs and 13 protein subunits of the electron transport
chain complexes (1). Therefore, human mtDNA is
dependent on nuclear-encoded proteins for replication,
repair, transcription and translation. This dependency
lies at the heart of several human diseases that are
caused by defects of mtDNA maintenance and expres-
sion (2). Human mitochondrial diseases can encompass
mutations of both mtDNA and nuclear DNA (3).
However, the identiﬁcation of mtDNA or OXPHOS
abnormalities in Parkinson’s disease, Alzheimer’s disease,
cancer and diabetes indicate that our understanding of
mitochondrial function in disease is still in its infancy
(4). The most signiﬁcant gaps in our knowledge of mito-
chondrial function and disease are in the regulation of
mitochondrial gene expression (5,6). This is particularly
important since remarkable tissue-, cell- and disease-spe-
ciﬁc variations have been observed in the expression of
diﬀerent mitochondrial RNAs, but cannot be explained
at present (7–9). Mitochondrial RNAs are transcribed as
part of long polycistronic, precursor transcripts that gen-
erally encompass the entire mtDNA and are processed by
removing interspersed tRNAs to release the individual
mRNAs and rRNAs (10). Therefore, large variations in
ratios of the 13 levels of individual mRNAs and their
proteins must be controlled at a post-transcriptional
level. Mitochondrial transcripts are subsequently polyade-
nylated at their 30 ends to yield the mature mRNAs, which
are translated on mitochondrial ribosomes, while tRNAs
and rRNAs are subject to speciﬁc nucleotide modiﬁca-
tions and CCA is added to the 30 end of tRNAs (11,12).
Little is known about how the levels of speciﬁc RNAs are
regulated in mammalian mitochondria.
The best-characterized RNA-binding protein known to
regulate mammalian mitochondrial gene expression is the
leucine-rich pentatricopeptide repeat cassette (LRPPRC)
protein (13–15). This was recently identiﬁed as a gene
causing the rare French–Canadian variant of Leigh syn-
drome, a debilitating neurodegenerative condition
resulting from mitochondrial cytochrome c oxidase deﬁ-
ciency (15). Mutation of the LRPPRC gene results in
decreased levels of the cytochrome oxidase (COX) I and
III mRNAs (14); however, the RNA sequence that this
protein binds has not been identiﬁed. LRPPRC is one
of the seven mammalian mitochondrial PPR domain
proteins, along with the mitochondrial RNA polymerase
(POLRMT), mitochondrial ribosomal protein of the small
subunit 27 (MRPS27), pentatricopeptide repeat domain
proteins (PTCD) 1, 2 and 3 and mitochondrial RNase P
protein 3 (MRPP3), which is a recently identiﬁed subunit
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(16,17). PPR domain proteins were identiﬁed ﬁrst in
plants, where they constitute a large family of mitochon-
drial and chloroplast proteins involved in transcript
processing, editing and translation (18). Recently, the
PPR domain protein PTCD2 was shown to regulate
cytochrome b RNA processing in mice (19), and we
found that PTCD3 associates with the mitochondrial
small ribosomal subunit and is important for protein
synthesis (20). The functions of the remaining PPR
domain proteins in mammalian mitochondria have not
been elucidated to date.
Here we have investigated the role of the previously
uncharacterized mammalian PTCD1 and show that it
associates with and regulates the level of leucine tRNAs
in mitochondria. We show that by decreasing PTCD1
we increase leucine tRNA levels in cells and consequently
observe an increased expression of mitochondrial-encoded
Complex I and IV subunits and increased Complex IV
activity.
MATERIALS AND METHODS
Plasmid expression vectors
All expression vectors were based on pcDNA3
(Invitrogen). Full-length human PTCD1 (NCBI accession
number NP_056360) was expressed with its native termin-
ation codon or fused to a tandem aﬃnity puriﬁcation tag
(TAP, ABO76910) (21) or EYFP (BD Biosciences) at the
C-terminus. All plasmids were tested for expression by
transfection and immunoblotting.
Cell culture
143B osteosarcoma cells were cultured at 378C under
humidiﬁed 95% air/5% CO2 in Dulbecco’s modiﬁed
Eagle’s medium (DMEM, Invitrogen) containing glucose
(4.5gl
–1), 1mM pyruvate, 2mM glutamine, penicillin
(100Uml
–1), streptomycin sulphate (100mgml
–1) and
10% fetal bovine serum (FBS). Rho
0 143B cybrids were
a gift from Dr Elizabeth Ledgerwood, University of
Otago, New Zealand and MELAS A3243G 143B
cybrids were a gift from Prof. Rudolf Wiesner,
University of Ko ¨ ln, Germany, with permission from Dr
Eric Shoubridge. These were grown in the same medium
supplemented with uridine (50mgl
–1).
Mitochondrial isolation and subfractionation
Mitochondria were prepared from 10
7 cells grown over-
night in 15cm
2 dishes and isolated as described before
(22). Rat liver mitochondria were prepared by homogen-
ization in 250mM sucrose, 5mM Tris–HCl pH 7.4 and
1mM EGTA (STE) followed by diﬀerential centrifugation
(23) and the protein concentration determined by the
biuret assay using BSA as a standard (24). Rat liver
mitochondria were washed and suspended in STE
containing 0.1% (w/v) fat-free BSA (STE/BSA) instead
of STE for the ﬁnal spin. The ﬁnal pellet was suspended
in a minimal amount of STE/BSA and the protein
concentration was measured by the biuret assay.
The mitochondria were diluted with STE/BSA to a ﬁnal
concentration of 100mgml
–1 and stirred on ice. One milli-
litre of digitonin (12.5mgml
–1) was added dropwise over
2min and the solution was kept on ice for a further
13min. Three volumes of STE/BSA were added and the
mixture was homogenized four times with a tight hom-
ogenizer. The mitoplasts were collected by centrifugation
for 10min at 10000g and the concentration was measured
using the biuret assay. The supernatant was kept and
centrifuged at 144000g for 20min at 58C to separate the
intermembrane fraction (supernatant) from the outer
membrane (pellet). The mitoplasts were suspended at
30mgml
–1 in STE containing 0.16mg lubrol mg
–1
mitoplast protein and incubated on ice for 20min. This
solution was diluted with three volumes of STE and
centrifuged at 144000g for 50min at 58C to separate
the matrix (supernatant) from the inner membrane
(pellet). Both membrane fractions were suspended in
1% lauryl maltoside in STE. The protein concentration
of each fraction was determined using the BCA assay
(25) and immunoblotting was carried out to conﬁrm the
fractionation.
Transfections
143B cells were plated at 60% conﬂuence in six-well plates
or 10-cm dishes and transfected with annealed siRNAs
or mammalian expression plasmids in OptiMEM media
(Invitrogen). A total of 125nM (for six-well plates) or
145nM (for 10-cm dishes) of PTCD1 or control, oﬀ-
target siRNAs (Dharmacon) were transfected using
Lipofectamine 2000 (Invitrogen). A total of 158ng/cm
2
of PTCD1 or control EYFP plasmid DNA was trans-
fected using Fugene HD (Roche). Cell incubations were
carried out for up to 72h following transfection. PTCD1
expression was detected by immunoblotting using a poly-
clonal PTCD1 antibody.
Fluorescence cell microscopy
For immunocytochemistry, 143B cells were plated onto
13-mm diameter glass coverslips and allowed to attach
overnight. Non-transfected cells were ﬁxed with 4%
paraformaldehyde in Tris buﬀered saline (TBS) for
30min, washed with TBS and incubated with 10% FCS/
0.1% Triton X-100/TBS (TBST) for 10min. The PTCD1
antibody (1:500) diluted in TBST was added and
incubated for 3h at room temperature. After washing
with TBS (3 5min) the cells were incubated with anti-
rabbit IgG Oregon green secondary antibody (diluted
1:100 in TBS) (Molecular Probes) for 15min in the
dark. Cells were then washed in TBS. Alternatively, cells
were transfected with pPTCD1-EYFP for 48h, and at the
end of the incubation treated with 100nM Mitotracker
Orange for 15min, then ﬁxed with 4% paraformaldehyde
in TBS for 30min and washed with TBS. Cells were
mounted in DABCO/PVA medium. Images were
acquired using an Olympus DP70 ﬂuorescent inverted
microscope using a Nikon 40  objective.
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143B cells were lysed in 50mM Tris/HCl (pH 7.5),
125mM NaCl, 5% glycerol, 1% Igepal CA-630, 1.5mM
MgCl2, 1mM DTT, 25mM NaF, 1mM Na3VO4,1 m M
EDTA, 1  complete protease inhibitors (Roche),
200Uml
–1 RNaseOUT (Invitrogen) at 48C. The lysate
was cleared by centrifugation and incubated with rabbit-
IgG agarose (Sigma) at 48C for 2h. The agarose was
washed with lysis buﬀer and then with 10mM Tris/HCl,
pH 7.5, 150mM NaCl, 0.5mM EDTA, 1% Igepal CA-
630, 200U.ml
–1 RNaseOUT and protein was eluted by
addition of 10U of AcTEV protease (Invitrogen, RT for
1h). RNA was isolated using the miRNeasy Mini kit
(Qiagen) incorporating an on-column RNase-free DNase
digestion to remove all DNA. For slot blotting, RNA was
isolated from 5 10
7 143B cells expressing PTCD1-TAP
or EYFP-TAP by aﬃnity puriﬁcation as described above.
The entire sample of puriﬁed RNA was applied to a
Hybond-N
+ nitrocellulose membrane using a Bio-Dot
SF microﬁltration apparatus (BioRad) and probed as
described for the northern blots.
Quantitative RT–PCR
The transcript abundance of mitochondrial genes and pre-
processed junctions was measured on RNA isolated from
143B cells using the miRNeasy RNA extraction kit
(Qiagen). Levels of PTCD1 mRNA were measured from
RNA isolated from normal human tissues (Ambion).
cDNA was prepared using ThermoScript reverse tran-
scriptase (Invitrogen) and random hexamers and used as
a template in the subsequent PCR that was performed
using a Corbett Rotorgene 3000 using Platinum UDG
SYBR Green mastermix (Invitrogen) and normalized to
18S ribosomal RNA. Primer sequences are listed in
Supplementary Table 1.
Northern blotting
RNA (20mg) was resolved on 1.2% agarose formaldehyde
gels, then transferred to 0.45mm Hybond-N
+ nitrocellu-
lose membrane (GE Lifesciences) and hybridized with
biotinylated oligonucleotide probes speciEc to mitochon-
drial tRNAs (Supplementary Table 1). The hybridizations
were carried out overnight at 508Ci n5   SSC, 20mM
Na2HPO4, 7% SDS and 100mgml
–1 heparin, followed by
washing. The signal was detected using a streptavidin-
linked horseradish peroxidase (diluted 1:2000 in 3 
SSC, 5% SDS, 25mM Na2HPO4, pH 7.5) by enhanced
chemiluminescence (GE Lifesciences).
Immunoblotting
Speciﬁc proteins were detected using a mouse ND1
monoclonal antibody (diluted 1:2000, Santa Cruz
Biotechnology), NDUFA9, COXI, COXII and COXIV
(MitoSciences, diluted 1:2000), Bcl-2 antibody (Zymed,
diluted 1:500) in 1% skim milk powder in phosphate-
buﬀered saline (PBS). Control immunoblots against
porin (MitoSciences, diluted 1:2000) were used to conﬁrm
normalized protein loading. Control immunoblots of the
cytosol fractions against the MnSOD antibody showed
complete separation of the mitochondria from the cytosol.
Respiration
Permeabilized cell respiration on glutamate/malate was
measured according to Kuznetsov et al. (26). Brieﬂy,
1 10
6 cells were washed in PBS, resuspended in 0.25ml
mitomedium B (0.5mM EGTA, 3mM MgCl2,2 0 m M
taurine, 10mM KH2PO4, 20mM HEPES, 1gl
–1 fatty
acid-free BSA, 60mM lactobionate, 110mM mannitol,
0.3mM DTT, pH 7.1 with KOH) and added to 0.5ml
mitomedium B in a 1ml Rank Brothers Oxygen
Electrode thermostatically maintained at 378C. The
system was left to equilibrate for 5min, before adding
digitonin (50mgml
–1) and waiting for 5min for the
oxygen consumption to decline. Respiration of the
permeabilized cells was initiated with 10mM glutamate
and 5mM malate.
Complex enzyme assays
Enzyme assays were carried out in a 1ml cuvette at 308C
using a Perkin Elmer lambda 35 dual beam spectropho-
tometer. For mitochondrial oxidative phosphorylation
complex assays, mitochondria in STE plus protease
inhibitors were disrupted by two to four cycles of
freezing in dry ice/ethanol and thawing at 308C.
Combined Complex II to Complex III activity was
assayed as the myxothiazol-sensitive rate of reduction
of ferricytochrome c by succinate (27). Complex III
was measured as the myxothiazol-sensitive rate of reduc-
tion of ferricytochrome c by CoQ2 and Complex IV
was measured as the cyanide-sensitive oxidation of
ferrocytochrome c (27).
RESULTS
PTCD1 is a mitochondrial matrix protein with eight
PPR domains
The uncharacterized PPR-domain protein PTCD1 has
been noted previously to share homology with the
Neurospora crassa protein CIA84 that is an assembly
factor for mitochondrial Complex I. However, the recip-
rocal best match of PTCD1 in N. crassa is the
uncharacterized protein NCU007871 (Supplementary
Figure 1) and the most distinctive features of PTCD1
are its eight PPR domains and an N-terminal mitochon-
drial targeting sequence (Figure 1A, Supplementary
Figure 2).
We measured the mRNA levels of PTCD1 in human
tissues and found that it is most abundant in testes,
skeletal muscle and heart (Figure 1B). We fused the
C-terminus of the protein to EYFP and showed that
PTCD1 localizes speciﬁcally to mitochondria in 143B
cells (Figure 1C). We used an antibody to PTCD1 to
conﬁrm its localization to mitochondria (Figure 1C).
Fractionation of isolated mitochondria from rat liver
into the four compartments, followed by immunoblotting
of each fraction against a marker protein, indicated that
Nucleic Acids Research, 2009,Vol.37, No. 17 5861PTCD1 was predominantly a mitochondrial matrix
protein (Figure 1D).
PTCD1 associates with mitochondrial leucine tRNAs
We fused the C-terminus of PTCD1 to a TAP tag and
expressed this protein in 143B osteosarcoma cells. We
used the TAP tag to isolate the PTCD1-TAP protein
from cells and measured the enrichment of the 13 mito-
chondrial RNA transcripts by quantitative reverse tran-
scriptase PCR (QRT-PCR) to determine the RNA targets
of PTCD1. There was no signiﬁcant enrichment observed
of these transcripts compared to the control EYFP-TAP
protein (Figure 2A). Because many plant PPR domain
proteins are involved in processing of organelle
transcripts, we investigated if PTCD1 bound any of the
mitochondrial precursor RNAs. We designed primers
around the junctions between each gene and most of
these areas included tRNAs which are thought to act as
‘punctuation marks’ for most of the mammalian mRNA
transcripts. We found that two junction transcripts
were enriched in RNA associated with PTCD1-TAP:
RNA19 and ND4–5 (Figure 2B). The RNA19 transcript
encompasses the 16S rRNA, tRNA
Leu(UUR) and the ND1
RNA. The ND4–5 precursor transcript encompasses
the ND4 RNA, tRNA
His, tRNA
Ser, tRNA
Leu(CUN) and
the ND5 RNA. We quantitated the enrichment of the
tRNAs in each junction and found that the leucine
Figure 2. PTCD1 is a mitochondrial RNA-binding protein. PTCD1-
TAP protein expressed in 143B cells was puriﬁed using rabbit IgG
agarose and eluted by tobacco etch virus (TEV) protease cleavage.
RNA associated with the eluted PTCD1-TAP was reverse transcribed
and analysed by Q-PCR. Values are expressed as a ratio of PTCD1-
TAP compared to puriﬁcation from cells that express a control, EYFP-
TAP protein. (A) Enriched mitochondrial mRNA transcripts compared
to control. (B) Enrichment of mitochondrial RNA junction transcripts
compared to control (n.d., not detected). (C) Enrichment of leucine
tRNAs compared to control. Data are means SD of three separate
experiments. (D) Enrichment of leucine tRNAs but not 12S rRNA,
conﬁrmed by slot blotting using biotinylated oligonucleotide probes.
Figure 1. PTCD1 is a mitochondrial matrix protein with eight PPR
domains. (A) Gene structure of PTCD1. (B) mRNA distribution in
human tissues analysed by Q-PCR. (C) 143B cells transfected with
pPTCD1-EYFP or untreated143B cells were incubated with 100nM
Mitotracker Orange and ﬁxed. PTCD1-EYFP (green) was co-localized
to mitochondria stained with Mitotracker Orange (red) directly by
ﬂuorescence microscopy and untreated cells were incubated with an
antibody against PTCD1 (green). In the overlaid images yellow
indicates co-localization of PTCD1 with mitochondria. Scale bar is
5mm. (D) Isolated mitochondria were fractionated into four
compartments; proteins from each fraction were resolved by SDS–
PAGE and marker proteins for each mitochondrial compartment
were detected by immunoblotting. We detected Bcl-2 as a marker for
the outer mitochondrial membrane, NDUAF9 as the marker for the
inner mitochondrial membrane and MnSOD as a marker for the mito-
chondrial matrix. PTCD1 is associated predominantly with the mito-
chondrial matrix.
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Leu(UUR) and tRNA
Leu(CUN)) were targets
for PTCD1 (Figure 2C). To conﬁrm that the association
of PTCD1 with mitochondrial leucine tRNAs was speciﬁc
we isolated the enriched RNA from cells expressing
PTCD1-TAP or EYFP-TAP and detected the presence
of tRNA
Leu(UUR), tRNA
Leu(CUN) and 12S rRNA by
hybridization with biotinylated oligonucleotide probes
against these transcripts. We found that tRNA
Leu(UUR)
and tRNA
Leu(CUN) were speciﬁcally enriched in RNA
associated with PTCD1-TAP but not in the control
RNA isolated from cells expressing EYFP-TAP
(Figure 2D).
PTCD1 lowers the abundance of mitochondrial
leucine tRNAs
We investigated the eﬀects of PTCD1 knockdown and
overexpression in 143B cells. We used two distinct
siRNA duplexes that signiﬁcantly lowered the protein
levels of PTCD1 but did not aﬀect the abundance of
porin, which was used as a loading control (Figure 3A).
Next, we found that the mature mRNA and rRNA
transcripts were not aﬀected by knocking down or
overexpressing PTCD1 in 143B cells (Figure 3B)
suggesting that PTCD1 does not aﬀect processing of the
polycistronic mitochondrial mRNA in a way that changes
the abundance of the mature mRNAs. We investigated the
levels of mitochondrial mature transcripts by northern
blotting and found that they were not changed when
PTCD1 was knocked down or overexpressed
(Figure 3C). Then we investigated the eﬀect of PTCD1
knockdown and overexpression on the mitochondrial
RNA junctions and found that increasing PTCD1 abun-
dance reduced the precursor ND4–5 transcripts, whereas
decreasing PTCD1 30 abundance resulted in an increase of
the ND4–5 transcript (Figure 3D). RNA19 levels were not
signiﬁcantly aﬀected with the changes in PTCD1 abun-
dance. However, we observed that the levels of transcript
junctions ND1-2, ND2-tRNA
Ala and COI-COII increase
when PTCD1 is knocked down in cells (Figure 3D). Also,
we observed that the level of these transcript junctions is
decreased signiﬁcantly when the levels of PTCD1 is
increased (Figure 3D).
We investigated changes in mitochondrial tRNAs in
cells where PTCD1 was knocked down or overexpressed
by northern blotting. We observed a decrease of
tRNA
Leu(UUR) and tRNA
Leu(CUN) when PTCD1 was
overexpressed in cells either wild type or as a TAP
fusion, respectively (Figure 4A and B). Knockdown of
PTCD1 in cells led to increased accumulation of both leu-
cine tRNAs using two distinct siRNA duplexes (Figure 4A
and B). Changes in cellular PTCD1 levels did not aﬀect
the abundance of other tRNAs such as tRNA
Gln,
tRNA
Trp, tRNA
Ala (Figure 4C–E), nor the levels of
tRNA
Ser(AGY) and tRNA
His associated with the ND4–5
precursor transcript (Figure 4F–G).
PTCD1 knockdown leads to an increase in mitochondrial
and nuclear-encoded subunits of Complexes I and IV
Changes in mitochondrial tRNA levels have been
shown to aﬀect the translation of mitochondrial-encoded
genes (28). Therefore, we investigated, by immunoblot-
ting, diﬀerences in mitochondrial-encoded proteins in
143B cells where PTCD1 was knocked down or
overexpressed. We found increased protein levels of
subunits I and II of Complex IV when PTCD1 was
knocked down and decreased levels of these proteins
when PTCD1 was overexpressed in the cells (Figure 5A).
We observed the same trend with the ND1 subunit of
Complex I (Figure 5B). In addition, there are possibly
subtle changes in the levels of nuclear-encoded subunits
subunit IV of Complex IV and NDUFA9 of Complex I
(Figure 5A and C). We used porin as a loading control to
show that the mitochondrial protein abundance was equal
under all treatment conditions (Figure 5A–C).
Functional effects of PTCD1 knockdown and
overexpression
Because we observed changes in several subunits of
Complexes I and IV, we measured if their activities were
aﬀected when PTCD1 was knocked down or
overexpressed in 143B cells. The activity of Complex I
measured by respiration of digitonin-permeabilized cells
on glutamate/malate was not aﬀected signiﬁcantly when
PTCD1 was knocked down in 143B cells (Figure 6A).
However, enzyme assays showed an increased Complex
IV activity when PTCD1 was knocked down in cells
(Figure 6B). The enzyme activities of Complexs II to III
and Complex III were unaﬀected by the changes in
PTCD1 abundance (Figure 6C and D).
DISCUSSION
Here we show that PTCD1 is a mitochondrial matrix pro-
tein that is more abundant in mitochondria-rich tissues.
Comparative genomic analyses have predicted PTCD1 to
be an assembly factor for Complex I because of some
shared homology with the N. crassa protein CIA84.
Since PTCD1 is associated with both the mitochondrial
matrix and the inner membrane, it could be considered
that PTCD1 may have two functions within mitochon-
dria, as an RNA-binding protein and a Complex I assem-
bly factor. In this study we found that PTCD1 has an
important role as an RNA regulator.
The eight predicted PPR domains most likely give
PTCD1 RNA-binding aﬃnity for the leucine tRNAs
(tRNA
Leu(CUN) and tRNA
Leu(UUR)) and the precursor
RNAs that contain them. This suggests that the binding
of PTCD1 to the tRNAs does not require aminoacylation
nor CCA addition at the 30 end of the tRNAs.
Overexpression of PTCD1 reduced the levels of leucine
tRNAs in cells, while siRNA knockdown of PTCD1
increased the levels of these tRNAs. In addition, we
show that increasing the abundance of PTCD1 in cells
decreased the levels of precursor ND4–5 RNA as a result
of reduced tRNA
Leu(CUN) levels. The tRNA
Leu(UUR) levels
have a more subtle decrease which is not apparent at the
RNA19 level. Changing PTCD1 levels aﬀected some other
precursor RNAs; however, the levels of the tRNAs
contained within these transcripts that we investigated
were not changed. It is not clear if these represent genuine
Nucleic Acids Research, 2009,Vol.37, No. 17 5863PTCD1 targets or whether these changes are a secondary
eﬀect of PTCD1 at the regions containing the leucine
tRNAs which aﬀects the rate or hierarchy of processing
of primary mtDNA transcripts. Because altered levels of
PTCD1 modulate the levels of leucine tRNAs without
aﬀecting the levels of the mRNAs that ﬂank them, it
seems unlikely that PTCD1 acts solely at the level of
RNA processing. Whether PTCD1 induces cleavage of
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Figure 3. PTCD1 changes the level of precursor RNAs in 143B cells. (A) Protein expression of PTCD1 following knockdown by speciﬁc and non
targeting siRNA in cells was detected by immunoblotting. Porin was detected to check for equal loading of total protein. (B) Changes in PTCD1
levels do not aﬀect mature mRNA and rRNA abundance. RNA isolated from cells transfected with PTCD1 siRNA, non-targeting (NT) siRNA, a
plasmid that overexpresses PTCD1 (pPTCD1) or a plasmid that overexpresses EYFP (pEYFP) was reverse transcribed and analysed by Q-PCR. The
data is expressed as a ratio of transcripts from experimental samples compared to control samples. Ampliﬁcation of mature mitochondrial mRNA
transcripts is shown. (C) The abundance of mature mitochondrial transcripts was analysed by northern blotting. The data are typical of results
repeated on two separate RNA preparations. (D) Ampliﬁcation of precursor RNA transcripts by Q RT-PCR. Data are means SD of three separate
experiments.
5864 Nucleic Acids Research, 2009, Vol. 37,No. 17the leucine tRNAs before or after RNase P and RNase Z
cleavage remains to be determined. The observation that
mRNA levels are not changed implies that either PTCD1
has an eﬀect after tRNA processing or that mRNA
processing can proceed even if the intervening tRNA is
cleaved. This suggests a negative regulatory function of
PTCD1 at the tRNA level that does not severely aﬀect
the processing and translation of mitochondrial tran-
scripts. This contrasts with a recent study where mice
lacking the PTCD2 gene showed an increase in a precursor
RNA containing cytochrome b and a concomitant
decrease in mature cytochrome b mRNA (19).
The enrichment of leucine tRNAs with PTCD1 from
cells was detected using primers that bind only within
the tRNAs, which are present at higher amounts than
the precursor RNAs that contain them. Although a
high-resolution structure of a PPR domain has not yet
been described, structural modelling has led to the pro-
posal that PPR domains most likely bind single-stranded
RNA (29). Since tRNAs have mostly double-stranded
structures, there could be two possible modes of associ-
ation between PTCD1 and leucine tRNAs; PTCD1 could
either bind sequences found in the loop regions of
properly folded tRNA or it could bind in regions that
are double stranded in the properly folded tRNA by
associating before the tRNA has folded or by displacing
the non-target strand to enable its association. The deg-
radation of leucine tRNAs could result from nuclease
activity of PTCD1; however, we could not identify any
regions of primary sequence with similarity to known
nuclease domains. Alternatively, PTCD1 may recruit
Figure 4. PTCD1 lowers the abundance of mitochondrial leucine
tRNA in 143B cells. RNA isolated from cells transfected with PTCD1
siRNA, NT siRNA, pPTCD1, pEYFP and from untransfected cells was
analysed for tRNA abundance by northern blotting. (A) tRNA
Leu(UUR).
(B) tRNA
Leu(CUN).( C) tRNA
Gln.( D) tRNA
Trp.( E) tRNA
Ala.
(F) tRNA
Ser(AGY).( G) tRNA
His.( H) Total RNA was detected using
methylene blue. The data are typical of results repeated on four separate
RNA preparations. Each northern blot was probed for all the tRNAs
by stripping the blot and re-probing it.
Figure 6. Functional eﬀects of PTCD1 knockdown and overexpression.
(A) State 4 respiration on glutamate/malate was measured in digitonin-
permeabilized 143B cells transfected with PTCD1 siRNA, NT siRNA,
pPTCD1 and pEYFP using an oxygen electrode. The enzyme activities
of cytochrome oxidase (B), Complexes II–III (C) and Complex III
(D) were measured spectrophotometrically. Data are means SEM of
four separate experiments;
 P<0.05 compared with control treatments
by a two-tailed paired Student’s t-test.
Figure 5. PTCD1 knockdown leads to an increase in mitochondrial
and nuclear-encoded subunits of Complexes I and IV. Mitochondria
were isolated from cells transfected with PTCD1 siRNA, NT siRNA,
pPTCD1, pEYFP and from untransfected cells. Mitochondrial proteins
were resolved by SDS–PAGE and speciﬁc proteins were detected by
immunoblotting. (A) COXI, COXII, COXIV and porin. (B) ND1 and
porin (C) NDUFA9 and porin. The data are typical of results repeated
on four separate mitochondrial preparations (one of which is shown in
the supplementary Figure 6).
Nucleic Acids Research, 2009,Vol.37, No. 17 5865nucleases that cleave the leucine tRNAs or rearrange the
tRNA structure to produce a substrate for a nuclease
activity not directly associated with PTCD1. We have
found that PTCD1 is insoluble when expressed in
Escherichia coli and in wheat germ extract, which has
made functional in vitro studies diﬃcult. The ability to
generate soluble recombinant PTCD1 will be critical for
functional analysis of the RNA-binding aﬃnities and
minimal recognition sites. Towards this goal we are
investigating the binding aﬃnity of individual PTCD1
domains for the leucine tRNAs.
The targeted destruction of tRNAs has been observed
in the cytoplasm of a variety of diverse organisms ranging
from bacteria and plants to mammalian cells (30,31).
To the best of our knowledge this phenomenon has been
observed here in an organelle for the ﬁrst time. The deple-
tion of tRNA provides a rapid way to lower protein trans-
lation in response to cellular stresses such as oxidative
stress, nutrient deprivation and amino acid starvation
(31). Increased leucine tRNAs in response to PTCD1
knockdown increased mitochondrial-encoded Complexes
I and IV subunits, suggesting that leucine tRNAs may
be rate-limiting for mitochondrial protein synthesis.
The subtle increases in nuclear-encoded subunits of
Complexes I and IV are most likely a retrograde response
to the increased mitochondria-encoded subunits. We have
investigated the eﬀects of PTCD1 overexpression and
knockdown on de novo mitochondrial protein synthesis
in 143B cells and found that there were subtle but
not signiﬁcant diﬀerences in the abundance of the
13 mitochondria-encoded proteins (Supplementary
Figure 5). The subtle protein changes over 1h of de novo
synthesis may accumulate over time to yield signiﬁcant
diﬀerences in the steady state levels of the proteins after
knockdown or overexpression of PTCD1, as detected by
immunoblotting. This is consistent with the observed
functional increase in the activity of Complex IV
following PTCD1 knockdown. We have observed that
cybrids devoid of mitochondrial DNA or cybrids with a
mutation in the tRNA
Leu(UUR) that causes MELAS, have
increased levels of PTCD1 (Supplementary Figure 7).
Although the physiological inducers of PTCD1 remain
to be identiﬁed, this suggests that PTCD1 may play a
role in the regulation of mitochondrial gene expression
in response to stress.
In mammals mitochondrial transcripts lack introns and
untranslated regions and rely on tRNA processing to gen-
erate mature RNAs, whereas in yeast mitochondrial
transcripts have 50 untranslated regions that regulate
translation and plant mitochondrial transcripts are
edited and have introns. The diverse regulatory
functions of PPR proteins may have evolved in diﬀerent
organisms as a result of the idiosyncratic features of
organelle gene expression between diﬀerent kingdoms.
Mammalian PPR domain proteins studied to date regulate
mitochondrial gene expression by diﬀerent mechanisms:
POLRMT transcribes mtDNA (5), PTCD2 processes spe-
ciﬁc precursor RNAs (19), LRPPRC stabilizes speciﬁc
mRNAs (14), PTCD3 associates with the small ribosomal
subunit and is necessary for eﬃcient translation (20) and
MRPP3 is a subunit of the RNase P complex needed for
processing of tRNAs (16). We have expanded the reper-
toire of PPR protein function by showing that PTCD1
acts as a negative regulator of speciﬁc mitochondrial
tRNAs. Further characterization of mammalian PPR
domain proteins will provide insights into the regulation
of mitochondrial gene expression at a post-transcriptional
level.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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